T. Rowe Price Investment Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-689
Closed -$5K 814
2025
Q4
$5K Hold
689
﹤0.01% 786
2025
Q3
$4K Sell
689
-4,409,996
-100% -$21.6M ﹤0.01% 799
2025
Q2
$22.8M Buy
+4,410,685
New +$26.4M 0.01% 488
2024
Q4
Sell
-4,481,379
Closed -$31.4M 656
2024
Q3
$31.4M Sell
4,481,379
-2,467,209
-36% -$14.8M 0.02% 474
2024
Q2
$34.1M Buy
+6,948,588
New +$41.9M 0.02% 447

Other funds holding LFST

T. Rowe Price Investment Management's LFST Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 689 shares — an estimated $5K sold.

T. Rowe Price Investment Management first reported a position in LFST in Q2 2024 and held it in 5 quarters. The position peaked at $34.1M in Q2 2024. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 689 Lifestance Health shares in Q1 2026, an estimated $5K.
  • T. Rowe Price Investment Management first reported a position in Lifestance Health in Q2 2024 and held it in 5 quarters.
  • T. Rowe Price Investment Management's Lifestance Health position peaked at $34.1M in Q2 2024.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.